维普期刊资源整合服务平台（V6.5）

67篇 您的检索式：作者名="AS Bomback"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD:a systematic review显示文摘	Bomback AS Kshirsagar AV Amamoo MA	2008	Am J Kidney Dis2008，51，2：	1
2	Diabetic cardiovascular disease predicts chronic kidney disease awareness in the kidney early evaluation program 显示文摘	WhaleyConnell A Bomback AS McFarlane SI	2011	Cardiorenal Med2011，1，1：	1
3	KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomemlonephritis显示文摘	Beck L Bomback AS Choi MJ		0，，03：	1
4	Eculizumab for dense deposit disease and C3 glomerulonephritis 显示文摘	Bomback AS Smith R J Barile GR	2012	Clin J Am Soc Nephrol2012，7，5：	1
5	Glomerular disease: ANCA- associated GN-- to PLEX or not to PLEX? 显示文摘	Bomback AS Appel GB	2013	Nat Rev Nephrol2013，9，8：	1
6	Pathology after eculizumab in dense deposit disease and C3 GN显示文摘	Herlitz LC Bomback AS Markowitz GS		0，，：	1
7	Eculizumab for dense deposit disease and C3 glomerulonephritis 显示文摘	Bomback AS Smith RJ Baffle GR	2012	Clin J Am Soc Nephrol2012，7，5：	1
8	Eculizumab for dense deposit disease and C3 glomerulonephritis显示文摘	Bomback AS Smith RJ Barile GR		0，，：	1
9	Pathogenesis of the C3 glomerulopa-thies and reclassification of MPGN显示文摘	Bomback AS Appel GB	2012	Nat Rev Nephrol2012，8，11：	1
10	A new apolipoprotein E mutation,apoE Las Vegas,in a European-American with lipoprotein glomerulopathy显示文摘	Bomback AS Song H D'Agati VD		0，，10：	1
11	Development and validation of a patient self - assessment score for diabetes risk 显示文摘	Bang H Edwards AM Bomback AS	2009	Ann InternMed2009，151，11：	1
12	The incidence and implications of aldosterone breakthrough显示文摘	Bomback AS Klemmer PJ		0，，：	1
13	Eculizumab fordensedeposit disease and C3 glomerulonephritis显示文摘	Bomback AS Smith RJ Barile GR	2012	Clin J AmSoc Nephrol2012，7，5：	1
14	Treament of nephrot- ic syndrome with adrenoeorticotropie harmonea (ACTH) gel 显示文摘	Bomback AS Tumlin JA Baranski J	2011	Drug Des Devel Ther2011，5，：	1
15	Oral paricalcitol as antiproteinuric agent in chronic kidney disease显示文摘	de Lorenzo A Salanova L Bomback AS	2013	Nefrologia2013，33，5：	1
16	Development and validation of a patient self-assessment score for diabetes risk 显示文摘	Bang H Edwards AM Bomback AS	2009	Ann Intern Med2009，151，11：	1
17	Treatment of idiopathic FSGS with adrenocorticotropic hormone gel显示文摘	Hogan J Bomback AS Mehta K	2013	Clin J Am Soc Nephrol2013，8，12：	1
18	Rituximab therapy for membranous nephropathy:a systematic review显示文摘	Bomback AS Derebail VK McGregor JG	2009	Clin J Am Soc Nephrol2009，4，：	1
19	The associa- tion of parathyroid hormone with esrd and pre-esrd mortality in the kidney early evaluation program显示文摘	Saab G Bomback AS mcfarlane SI	2012	J Clin Endocrin & Metabo2012，97，12：	1
20	Updates on the treatment of lupus nephritis显示文摘	AS Bomback G B Appel	2010	J Am Soc Nephrol2010，21，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示